Form D/A - Notice of Exempt Offering of Securities: [Amend]
SEC Accession No. 0001816829-23-000001
Filing Date
2023-07-13
Accepted
2023-07-13 15:16:05
Documents
1
Effectiveness Date
2023-07-13
Items
Item 06b:
Item 3C: Investment Company Act Section 3(c)
Item 3C.7: Section 3(c)(7)

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D/A  
1 primary_doc.xml D/A 6222
  Complete submission text file 0001816829-23-000001.txt   7463
Mailing Address C/O HIGHVISTA STRATEGIES LLC 200 CLARENDON STREET, 50TH FLOOR BOSTON MA 02116
Business Address C/O HIGHVISTA STRATEGIES LLC 200 CLARENDON STREET, 50TH FLOOR BOSTON MA 02116 (617) 406-6500
HighVista Biotechnology Opportunities Fund LP (Filer) CIK: 0001816829 (see all company filings)

EIN.: 851099620 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D/A | Act: 33 | File No.: 021-371199 | Film No.: 231086633